1. A New Standard of Care: Pembrolizumab in Programmed Death-ligand 1 Positive, Metastatic, Triple-negative Breast Cancer. Issue 2 (2021) Authors: Johnson, Kai CC; Wesolowski, Robert; Gatti-Mays, Margaret E Journal: Touch reviews in oncology & haematology Issue: Volume 17:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Advanced and Metastatic Gastrointestinal Stromal Tumours: Review of Current Knowledge and Latest Advances. Issue 1 (2021) Authors: Barreto-Coelho, Priscila; Costa, Philippos Apolinario; Espejo-Freire, Andrea P; Jonczak, Emily; D'Amato, Gina Z; Trent, Jonathan C Journal: Touch reviews in oncology & haematology Issue: Volume 17:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Advances and Future Goals in Acute Myeloid Leukaemia Therapy. Issue 2 (2022) Authors: Bittar, Gianfranco; Oliveira-Gomes, Diana De; Rivero, Gustavo Journal: Touch reviews in oncology & haematology Issue: Volume 18:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Advances in Targeted Therapy for Patients with Neuroendocrine Tumours. Issue 1 (2022) Authors: Katiyar, Vatsala; Das, Satya Journal: Touch reviews in oncology & haematology Issue: Volume 18:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for EGFR-mutated Non-small Cell Lung Cancer. Issue 1 (2021) Authors: Guo, Matthew Z; Marrone, Kristen A; Spira, Alexander; Freeman, Kristine; Scott, Susan C Journal: Touch reviews in oncology & haematology Issue: Volume 17:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ATLAS: Risk-adapted Triplet Maintenance with Carfilzomib, Lenalidomide and Dexamethasone – Still Shrugging?. Issue 2 (2022) Authors: Franz, Joseph; Lonia, Sagar Journal: Touch reviews in oncology & haematology Issue: Volume 18:Issue 2(2022) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bruton's Tyrosine Kinase Inhibitors for the Treatment of Waldenström's Macroglobulinaemia: A Canadian Perspective. Issue 2 (2021) Authors: Larose, Frederic; Chen, Christine I Journal: Touch reviews in oncology & haematology Issue: Volume 17:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cholangiocarcinoma: The Present and Future of Targeted Therapies. Issue 1 (2022) Authors: Kalyan, Aparna; Shroff, Rachna T Journal: Touch reviews in oncology & haematology Issue: Volume 18:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical Utility of Human Papillomavirus Circulating Tumour DNA in Human Papillomavirus-positive Head and Neck Squamous Cell Carcinomas. Issue 2 (2022) Authors: Yun, Karen M; Cohen, Ezra Journal: Touch reviews in oncology & haematology Issue: Volume 18:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. COVID Coagulopathy and Thrombosis: A Systematic Review. Issue 1 (2022) Authors: Asrani, Roshan; Bahou, Wadie F Journal: Touch reviews in oncology & haematology Issue: Volume 18:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗